Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,322 | 2,605 | 3,109 | 3,817 | 4,300 |
| Marketable Securities | N/A | 362 | N/A | 251 | 250 |
| Receivables | N/A | 250 | N/A | 197 | 230 |
| Other current assets | 612 | 0 | 527 | 0 | 30 |
| TOTAL | $2,934 | $3,217 | $3,636 | $4,265 | $4,810 |
| Non-Current Assets | |||||
| PPE Net | N/A | 9 | N/A | 11 | N/A |
| Intangibles | 0 | 1,101 | 0 | 1,037 | 0 |
| Other Non-Current Assets | 1,122 | 10 | 1,122 | 10 | 2,640 |
| TOTAL | $1,122 | $1,120 | $1,122 | $1,058 | $2,640 |
| Total Assets | $4,056 | $4,337 | $4,758 | $5,323 | $7,480 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 258 | 0 | 436 | 260 |
| TOTAL | $N/A | $258 | $N/A | $436 | $260 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $231 | $258 | $372 | $436 | $260 |
| Shareholders' Equity | |||||
| Common Shares | N/A | 6,624 | N/A | 6,606 | 6,600 |
| Retained earnings | N/A | -153,460 | N/A | -152,487 | -150,150 |
| Other shareholders' equity | 3,825 | 131 | 4,386 | 20 | 30 |
| TOTAL | $3,825 | $4,079 | $4,386 | $4,887 | $7,220 |
| Total Liabilities And Equity | $4,056 | $4,337 | $4,758 | $5,323 | $7,480 |